Future of business interaction
A study on the interaction between MedTech companies and hospitals
With this study, we shine a spotlight on the challenges in business interactions today. We aim to drive forward the discussion among stakeholders so as to find solutions that can be applied broadly, yielding benefits for all parties involved.
Health care the right way
Reducing low-value care
Billions of dollars are wasted annually in the United States on “low value” health care services such as unnecessary diagnostic tests, trips to the emergency room, and avoidable surgeries. Explore how some organizations globally are using innovative approaches and technologies to combat this issue.
The future of real-world evidence
A focus on end-to-end, AI-driven, internally developed solutions
Biopharma is placing greater emphasis on real-world evidence (RWE), a Deloitte life-sciences survey finds. RWE helps leaders show value for access, understand the patient journey, and provide more data.